Literature DB >> 1671751

Expression of growth factor receptors in human brain tumours.

N L Tuzi1, D J Venter, S Kumar, S L Staddon, N R Lemoine, W J Gullick.   

Abstract

The expression of the EGF receptor, c-erbB-2 and PDGF receptor proteins has been studied in a series of human brain tumour biopsies and cell lines. Western blotting was used to determine the amount of protein present and their intrinsic and ligand promoted enzyme activities were studied by immunoprecipitation followed by autophosphorylation. EGF receptors were found to be expressed at very high levels in 40% of primary tumour biopsies, but at uniformly low levels in tumour derived cell lines. The c-erbB-2 protein was not detected in tumour biopsies, but was present at variable, but low levels in extracts of tumour cell lines. PDGF receptors were also found at moderate to low levels in both primary tumours and cell lines. The EGF receptor gene was amplified in four out of 14 primary tumours and this generally correlated with high levels of protein expression. The c-erbB-2 gene was not amplified. Employing the polymerase chain reaction and sequence specific oligonucleotides as probes there was no evidence of mutations in the c-erbB-2 gene transmembrane region. These results suggest that alterations of expression of the EGF receptor may play a role in human brain tumours. There was however no evidence for aberrant expression of the c-erbB-2 protein. Additional experiments are required to assess the influence of PDGF receptor expression in brain tumour cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1671751      PMCID: PMC1971768          DOI: 10.1038/bjc.1991.54

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  51 in total

1.  c-erbB-2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study.

Authors:  V G Falck; W J Gullick
Journal:  J Pathol       Date:  1989-10       Impact factor: 7.996

2.  Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene.

Authors:  O Segatto; C R King; J H Pierce; P P Di Fiore; S A Aaronson
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

3.  Cultured endothelial cells produce a platelet-derived growth factor-like protein.

Authors:  P E DiCorleto; D F Bowen-Pope
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

4.  Specific receptors for platelet-derived growth factor on cells derived from connective tissue and glia.

Authors:  C H Heldin; B Westermark; A Wasteson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

5.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

6.  Oncogene-related growth factors and growth factor receptors in human malignant glioma-derived cell lines.

Authors:  G R Harsh; M L Rosenblum; L T Williams
Journal:  J Neurooncol       Date:  1989-05       Impact factor: 4.130

7.  Absence of abnormalities of the c-erbB-1 and c-erbB-2 proto-oncogenes in human thyroid neoplasia.

Authors:  N R Lemoine; F S Wyllie; J R Lillehaug; S L Staddon; C M Hughes; R Aasland; J Shaw; J E Varhaug; C L Brown; W J Gullick
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

8.  Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase.

Authors:  H P Kalofonos; T R Pawlikowska; A Hemingway; N Courtenay-Luck; B Dhokia; D Snook; G B Sivolapenko; G R Hooker; C G McKenzie; P J Lavender
Journal:  J Nucl Med       Date:  1989-10       Impact factor: 10.057

9.  A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.

Authors:  H Lehväslaiho; L Lehtola; L Sistonen; K Alitalo
Journal:  EMBO J       Date:  1989-01       Impact factor: 11.598

10.  Pattern of expression of c-erbB-2 oncoprotein in human fetuses.

Authors:  P Quirke; A Pickles; N L Tuzi; O Mohamdee; W J Gullick
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

View more
  13 in total

1.  Evaluation of systemically administered radiolabeled epidermal growth factor as a brain tumor targeting agent.

Authors:  W Yang; R F Barth; R Leveille; D M Adams; M Ciesielski; R A Fenstermaker; J Capala
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

2.  Ligand-independent dimerization of oncogenic v-erbB products involves covalent interactions.

Authors:  M A Adelsman; B K Huntley; N J Maihle
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

3.  A phase I trial of the farnesyl transferase inhibitor, SCH 66336, with temozolomide for patients with malignant glioma.

Authors:  Annick Desjardins; David A Reardon; Katherine B Peters; Stevie Threatt; April D Coan; James E Herndon; Allan H Friedman; Henry S Friedman; James J Vredenburgh
Journal:  J Neurooncol       Date:  2011-07-07       Impact factor: 4.130

Review 4.  The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: a historical - and futuristic - perspective.

Authors:  Jonathan L Finlay; Stergios Zacharoulis
Journal:  J Neurooncol       Date:  2005-12       Impact factor: 4.130

Review 5.  Signal transduction pathways and their relevance in human astrocytomas.

Authors:  M M Feldkamp; N Lau; A Guha
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

6.  Epidermal growth factor receptor expression in squamous cell lung carcinomas: an immunohistochemical and gene analysis in formalin-fixed, paraffin-embedded material.

Authors:  V Gorgoulis; A Giatromanolaki; A Karameris; C Tsatsanis; D Aninos; B Ozanne; M Veslemes; J Jordanoglou; R Trigidou; H Papastamatiou
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

7.  Epidermal growth factor receptor expression in oligodendroglial tumors.

Authors:  J Reifenberger; G Reifenberger; K Ichimura; E E Schmidt; W Wechsler; V P Collins
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

Review 8.  EGF receptor in neoplasia and metastasis.

Authors:  K Khazaie; V Schirrmacher; R B Lichtner
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

9.  Three dimensional structure of the transmembrane region of the proto-oncogenic and oncogenic forms of the neu protein.

Authors:  W J Gullick; A C Bottomley; F J Lofts; D G Doak; D Mulvey; R Newman; M J Crumpton; M J Sternberg; I D Campbell
Journal:  EMBO J       Date:  1992-01       Impact factor: 11.598

10.  Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer.

Authors:  N R Lemoine; S Jain; F Silvestre; C Lopes; C M Hughes; E McLelland; W J Gullick; M I Filipe
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.